An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic &amp; Efficacious in the Human Viral Influenza Challenge Model. Serum IgG &amp; Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection
PloS one